I am guessing that it is related to the phase 3 test of a therapeutic drug developed by Regeneron that is being tested to both help cure those infected and those that are in close contacts with infected people, but who themselves are not infected. It is my understanding that the drug is in deep phase 3 with regard to uninfected people, but in a combined phase 2/3 to treat those that are infected. This was the drug that the US pumped about $425M into in the first week of July. Roche, a Swiss based competitor, was developing a different drug. All of a sudden - last week - Roche dropped its own development and has now teamed up with Regeneron to create worldwide distribution. This never would have happened unless Roche reviewed the test results. Roche will handle all non US distribution.
I am only guessing that this is the news. But the announcement of the 6 pm press conference is very real.
I am only guessing that this is the news. But the announcement of the 6 pm press conference is very real.